Increased circulating IL-1β levels have been associated with the risk of developing type 2 diabetes [33], inasmuch as IL-1β contributes to inhibiting β-cell function and destroying β-cell mass [34,35] and impairs adipocyte insulin signaling [36]. Here, IL1B is linked to type 2 diabetes mellitus.